# Dendritic Killer Cell-based Immunotherapy for Solid Tumors

> **NCT02882659** · PHASE1 · UNKNOWN · sponsor: **FullHope Biomedical Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Hepatocellular Carcinoma
- Neoplasm Metastasis

## Interventions

- **BIOLOGICAL:** Dendritic Killer Cell (DKC)

## Key facts

- **NCT ID:** NCT02882659
- **Lead sponsor:** FullHope Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-01
- **Final completion:** 2017-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2016-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882659, "Dendritic Killer Cell-based Immunotherapy for Solid Tumors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02882659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*